One of our clients attending the Regulatory Information Management Conference heard that Parexel is looking to buy Documentum. This comes after the announcement that EMC is looking to sell it prior to the Dell merger. While it is a rumor at this point so not going into a long post – Parexel is a major player in life sciences drug development services business. Quick take:
- Would be a plus for Life Sciences companies looking for more from their existing Documentum as well as the life sciences practice/products/services of Documentum.
- Would be a minus for all other industries – (financial, utilities, retail…..) that Parexel isn’t interested in.
It is just a rumor so nothing more – add your thoughts below.